Pemazyre 9MG tab
Ended Awarded
- Contract number
- 36C25521F0003
- Awardee
-
Incyte Corporation UEI ZTM9U2G5VTK8
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,725
Award facts
- Contract value <1% obligated
- $556,967,347.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Wilmington, DE 19803, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Health Administration awarded Incyte Corporation a $556.97 million firm fixed price delivery order against their Pharmaceuticals and Drugs GSA Schedule contract. This order is to provide PEMAZYRE 9MG tablets to VHA facilities in Veterans Integrated Service Network 15. The place of performance is Incyte's location in Talleyville, Delaware and the period of performance runs from November 2020 through November 2021. No set aside designation or subcontractors are indicated. This order will support VHA's mission to provide healthcare services to eligible military veterans through the procurement of this oncology medication from Incyte Corporation, the prime contractor.
Quick answers
Who was awarded contract 36C25521F0003?
36C25521F0003 was awarded to Incyte Corporation by Veterans Integrated Service Network 15 (Veterans Health Administration) on November 4, 2020.
How much is contract 36C25521F0003 worth?
The government has obligated $12,725 on 36C25521F0003. Its current value, with exercised options, is $556,967,347.
Is contract 36C25521F0003 an order under another contract?
Yes. 36C25521F0003 is a delivery order under 36F79720D0189, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25521F0003 competed?
The extent of competition for 36C25521F0003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award